1. Home
  2. ESNT vs COGT Comparison

ESNT vs COGT Comparison

Compare ESNT & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essent Group Ltd.

ESNT

Essent Group Ltd.

N/A

Current Price

$66.14

Market Cap

5.8B

Sector

Finance

ML Signal

N/A

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

N/A

Current Price

$32.08

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ESNT
COGT
Founded
2008
2014
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.5B
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
ESNT
COGT
Price
$66.14
$32.08
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
★ $73.38
$55.82
AVG Volume (30 Days)
739.4K
★ 1.9M
Earning Date
11-06-2026
11-06-2026
Dividend Yield
★ 2.10%
N/A
EPS Growth
★ 0.73
N/A
EPS
★ 3.89
N/A
Revenue
★ $1,260,935,000.00
$7,871,000.00
Revenue This Year
$8.00
N/A
Revenue Next Year
$4.64
$4,637.35
P/E Ratio
$17.09
★ N/A
Revenue Growth
★ 1.45
N/A
52 Week Low
$55.34
$13.79
52 Week High
$70.37
$43.73

Technical Indicators

Market Signals
Indicator
ESNT
COGT
Relative Strength Index (RSI) 57.46 53.86
Support Level $63.90 $30.72
Resistance Level $67.48 $37.69
Average True Range (ATR) 1.64 1.25
MACD 0.60 0.40
Stochastic Oscillator 69.48 92.87

Price Performance

Historical Comparison
ESNT
COGT

About ESNT Essent Group Ltd.

Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: